Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities
Emily Rodrigues, Matthew S. Macauley
Cancers (2018) Vol. 10, Iss. 6, pp. 207-207
Open Access | Times Cited: 200

Showing 1-25 of 200 citing articles:

Harnessing innate immunity in cancer therapy
Olivier Demaria, Stéphanie Cornen, Marc Daëron, et al.
Nature (2019) Vol. 574, Iss. 7776, pp. 45-56
Closed Access | Times Cited: 755
Insights into the role of sialylation in cancer progression and metastasis
Christopher Dobie, Danielle Skropeta
British Journal of Cancer (2020) Vol. 124, Iss. 1, pp. 76-90
Open Access | Times Cited: 238
Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis
Heinz Laübli, Lubor Borsig
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 214
Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
Ernesto Rodríguez, Kelly Boelaars, Kari Brown, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 201
CD47–SIRPα-targeted therapeutics: status and prospects
Roy L. Maute, Jianqing Xu, I L Weissman
Immuno-Oncology Technology (2022) Vol. 13, pp. 100070-100070
Open Access | Times Cited: 81
Aberrant Sialylation in Cancer: Therapeutic Opportunities
Jennifer Munkley
Cancers (2022) Vol. 14, Iss. 17, pp. 4248-4248
Open Access | Times Cited: 70
Golgi pH, Ion and Redox Homeostasis: How Much Do They Really Matter?
Sakari Kellokumpu
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 119
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
Natália Rodrigues Mantuano, Marina Natoli, Alfred Zippelius, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001222-e001222
Open Access | Times Cited: 93
The Phagocytic Code Regulating Phagocytosis of Mammalian Cells
Tom O. J. Cockram, Jacob M. Dundee, Alma S. Popescu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 73
Carbohydrate Sulfation As a Mechanism for Fine-Tuning Siglec Ligands
Jaesoo Jung, Jhon R. Enterina, Duong T. Bui, et al.
ACS Chemical Biology (2021) Vol. 16, Iss. 11, pp. 2673-2689
Open Access | Times Cited: 58
Roles of glycosylation at the cancer cell surface: opportunities for large scale glycoproteomics
Tomislav Čaval, Frederico Alisson‐Silva, Flavio Schwarz
Theranostics (2023) Vol. 13, Iss. 8, pp. 2605-2615
Open Access | Times Cited: 42
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment
Hannah Egan, Oliver Treacy, Kevin Lynch, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112475-112475
Open Access | Times Cited: 38
ST6GAL1‐mediated aberrant sialylation promotes prostate cancer progression
Emma Scott, Emily Archer Goode, Rebecca Garnham, et al.
The Journal of Pathology (2023) Vol. 261, Iss. 1, pp. 71-84
Open Access | Times Cited: 25
Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone
Kirsty Hodgson, Margarita Orozco‐Moreno, Emily Archer Goode, et al.
EBioMedicine (2024) Vol. 104, pp. 105163-105163
Open Access | Times Cited: 15
Dissecting the Ability of Siglecs To Antagonize Fcγ Receptors
Kelli A. McCord, Chao Wang, Mirjam Anhalt, et al.
ACS Central Science (2024) Vol. 10, Iss. 2, pp. 315-330
Open Access | Times Cited: 13
Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engager
Zhuo Yang, Yingqin Hou, Geramie Grande, et al.
Nature Biomedical Engineering (2024) Vol. 8, Iss. 5, pp. 499-512
Closed Access | Times Cited: 9
Understanding the Glycosylation Pathways Involved in the Biosynthesis of the Sulfated Glycan Ligands for Siglecs
Jaesoo Jung, Edward N. Schmidt, Hua-Chien Chang, et al.
ACS Chemical Biology (2025)
Closed Access | Times Cited: 1
Insights into Siglec‐7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility
Cristina Di Carluccio, Luis Padilla‐Cortés, Marta Tiemblo‐Martìn, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands
Emily Rodrigues, Jaesoo Jung, Heajin Park, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 69
Sialic acid and biology of life: An introduction
Shyamasree Ghosh
Elsevier eBooks (2020), pp. 1-61
Closed Access | Times Cited: 68
Regulation of ST6GAL1 sialyltransferase expression in cancer cells
Kaitlyn A. Dorsett, Michael P. Marciel, Jihye Hwang, et al.
Glycobiology (2020) Vol. 31, Iss. 5, pp. 530-539
Open Access | Times Cited: 61
Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function
Gustavo Rodrigues Rossi, Edvaldo da Silva Trindade, Fernando Souza‐Fonseca‐Guimaraes
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 56
A sweet spot for macrophages: Focusing on polarization
Depeng Yang, Lijun Yang, Jialing Cai, et al.
Pharmacological Research (2021) Vol. 167, pp. 105576-105576
Closed Access | Times Cited: 52
Sialometabolism in Brain Health and Alzheimer’s Disease
Punam Rawal, Liqin Zhao
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 44
The role of endolysosomal trafficking in anticancer drug resistance
Noor Hussein, Saloni Malla, Mariah A. Pasternak, et al.
Drug Resistance Updates (2021) Vol. 57, pp. 100769-100769
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top